Equal-WT
WhaleScore 2.0
?
Versant Venture Management is based out of San Francisco. Versant Venture Management is a registered investment advisory firm Their last reported 13F filing for Q4 2023 included $388,843,408 in managed 13F securities
and a top 10 holdings concentration of 100.0%. Versant Venture Management's largest holding is RayzeBio Inc. with shares held of 5,158,161. Whalewisdom has at least 40 13F filings
2023-12-31
Top Buys (13F)
Name | % Change |
---|
2023-12-31
Top Sells (13F)
Name | % Change |
---|---|
UTRS Minerva Surgical Inc | 0.15% |
2023-12-31
13F Holdings Summary
Name | $ Change |
---|---|
RYZB RayzeBio Inc. | 82.47% |
CRSP CRISPR Therapeutics | 8.03% |
RPTX Repare Therapeutics | 4.97% |
GRTS Gritstone bio Inc | 1.87% |
PASG Passage Bio, Inc. | 1.29% |
2023-12-31
13F Activity
Market Value | $389m, Prior: $188m |
New Purchases | 0 stocks |
Added To | 0 stocks |
Sold out of | 1 stocks |
Reduced holdings in | 0 stocks |
Top 10 Holdings % | 100% |
Turnover %[1] | 14.29% |
Turnover Alt %[2] | 0% |
Time Held Top 20 | 11.7143 quarters |
Time Held Top 10 | 11.7143 quarters |
Time Held All | 11.71 quarters |
[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.
[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.
2023-12-31
13F Sector Allocation Over Time
2023-12-31
Analysis
Top 20 equal-weighted holdings. Performance numbers calculated through 2023-12-31